申请人:Isabel Elise
公开号:US20110301143A1
公开(公告)日:2011-12-08
Heterocyclic compounds of structural formula (I), or a pharmaceutically acceptable salt thereof, wherein W is a R
1
— substituted heteroaryl, R
1
is an heteroaryl ring substituted with an ester or carboxylic acid containing radical, X-T is N—CR
5
R
6
, C═CR
5
or CR
13
—CR
5
R
6
, Y is a bond or —C(O)—, a and b represent an integer selected from 1 to 4, and Ar is an optionally substituted phenyl or naphtyl, are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD) The heterocyclic compounds are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, atherosclerosis, obesity, diabetes, neurological disease, Metabolic Syndrome, insulin resistance, cancer, liver steatosis, and non-alcoholic steatohepatitis.
结构式(I)的杂环化合物,或其药学上可接受的盐,其中W是R1-取代的杂芳基,R1是取代有酯基或羧基的杂芳基环,X-T是N—CR5R6,C═CR5或CR13—CR5R6,Y是键或—C(O)—,a和b代表选自1到4的整数,Ar是可选择取代的苯基或萘基,是硬脂酰辅酶A 9-脱饱和酶(SCD)的抑制剂。这些杂环化合物对于预防和治疗与异常脂质合成和代谢有关的疾病非常有用,包括心血管疾病、动脉粥样硬化、肥胖症、糖尿病、神经系统疾病、代谢综合征、胰岛素抵抗、癌症、肝脂肪变性和非酒精性脂肪肝。